U tijeku je upis prve generacije polaznika Sveučilišnog poslijediplomskog specijalističkog studija “Internistička onkologija” .
Stručni studij
HLZ- ESMO RSS
- Second-Line Nivolumab Is Not Superior to Chemotherapy in SCLC 13. prosinca 2018.
- First Line Immunotherapy Combination Fails to Improve Overall Survival in Lung Cancer [ESMO Press Release] 13. prosinca 2018.
- Changes in Oncology Trials Design After Initiation of Patient Accrual 12. prosinca 2018.
- ESMO Immuno-Oncology Congress Showcases New Technologies Set to Improve Cancer Treatment [ESMO Press Release] 11. prosinca 2018.
- Death Rates from Cancer will Fall in Australasian Countries and Russia in 2018: Researchers Call for Urgent Measures on Tobacco control, Especially in Russia [Annals of Oncology Press Release] 10. prosinca 2018.